Clinical evaluation of diabetic neuropathy in adult patients with type 1 diabetes and its possible association with insulin resistance

Fuente: Redalyc
Salvato in:
Dettagli Bibliografici
Autore principale: Claudia González-Milán
Natura: Artículo científico
Lingua:en
Pubblicazione: Instituto Mexicano del Seguro Social 2017
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1876478355884212224
author Claudia González-Milán
author_facet Claudia González-Milán
contents Clinical evaluation of diabetic neuropathy in adult patients with type 1 diabetes and its possible association with insulin resistance Claudia González-Milán Claudia Ramírez-Rentería Mario Molina-Ayala Aldo Ferreira-Hermosillo Medicina Type 1 Diabetes Mellitus Metabolic Syndrome Diabetic Neuropathies Background: In Mexico, there is a lack of information regarding the prevalence and characteristics of Diabetic Neuropathy (DN) in patients with type 1 diabetes (T1D). Although it was considered as a country with low-incidence of T1D, recent publications show that T1D frequency is under-represented. The aim of this paper is to describe the frequency and severity of DN in patients with T1D using a clinical scale and assess its possible association with insulin resistance. Methods: We evaluated 48 patients from T1D Clinic. We assessed clinical and biochemical characteristics and determined insulin resistance through estimated glucose dispose rate (eGDR). Patients underwent a neurologic evaluation using a previously validated score. Results: Seventy-three percent of patients had DN (54% mild and 19% moderate neuropathy). Twenty-nine percent of total population had Metabolic Syndrome. Major predictor factors for DN were the presence of diabetes for more than 13 years (OR 4.6, CI95%: 1.09-15.7), achieving treatment goals during the first 5 years (OR 0.22, CI95%: 0.05-0.87) and eGDR > 7.32 mg/kg/min (OR 0.096, CI95%: 0.011-0.81). Conclusions: The clinical scale performed in this study is a useful screening tool for DN in adults with long-standing T1D. DN is more frequent in patients with longer evolution of diabetes and poor glucose control during the initial years after diagnosis as expected, but insulin resistance should also be considered as an additional risk factor in this group. 2017 artículo científico 0443-5117 https://www.redalyc.org/articulo.oa?id=457755452012 https://www.redalyc.org/journal/4577/457755452012/ https://www.redalyc.org/journal/4577/457755452012/html/ https://www.redalyc.org/journal/4577/457755452012/457755452012.epub https://www.redalyc.org/journal/4577/457755452012/movil en http://www.redalyc.org/revista.oa?id=4577 Revista Médica del Instituto Mexicano del Seguro Social application/pdf Instituto Mexicano del Seguro Social Revista Médica del Instituto Mexicano del Seguro Social (México) Num.4 Vol.55
format Artículo científico
id redalyc_457755452012
institution Redalyc
language en
publishDate 2017
publisher Instituto Mexicano del Seguro Social
spellingShingle Clinical evaluation of diabetic neuropathy in adult patients with type 1 diabetes and its possible association with insulin resistance
Claudia González-Milán
Medicina
Type 1
Diabetes Mellitus
Metabolic Syndrome
Diabetic Neuropathies
Clinical evaluation of diabetic neuropathy in adult patients with type 1 diabetes and its possible association with insulin resistance Claudia González-Milán Claudia Ramírez-Rentería Mario Molina-Ayala Aldo Ferreira-Hermosillo Medicina Type 1 Diabetes Mellitus Metabolic Syndrome Diabetic Neuropathies Background: In Mexico, there is a lack of information regarding the prevalence and characteristics of Diabetic Neuropathy (DN) in patients with type 1 diabetes (T1D). Although it was considered as a country with low-incidence of T1D, recent publications show that T1D frequency is under-represented. The aim of this paper is to describe the frequency and severity of DN in patients with T1D using a clinical scale and assess its possible association with insulin resistance. Methods: We evaluated 48 patients from T1D Clinic. We assessed clinical and biochemical characteristics and determined insulin resistance through estimated glucose dispose rate (eGDR). Patients underwent a neurologic evaluation using a previously validated score. Results: Seventy-three percent of patients had DN (54% mild and 19% moderate neuropathy). Twenty-nine percent of total population had Metabolic Syndrome. Major predictor factors for DN were the presence of diabetes for more than 13 years (OR 4.6, CI95%: 1.09-15.7), achieving treatment goals during the first 5 years (OR 0.22, CI95%: 0.05-0.87) and eGDR > 7.32 mg/kg/min (OR 0.096, CI95%: 0.011-0.81). Conclusions: The clinical scale performed in this study is a useful screening tool for DN in adults with long-standing T1D. DN is more frequent in patients with longer evolution of diabetes and poor glucose control during the initial years after diagnosis as expected, but insulin resistance should also be considered as an additional risk factor in this group. 2017 artículo científico 0443-5117 https://www.redalyc.org/articulo.oa?id=457755452012 https://www.redalyc.org/journal/4577/457755452012/ https://www.redalyc.org/journal/4577/457755452012/html/ https://www.redalyc.org/journal/4577/457755452012/457755452012.epub https://www.redalyc.org/journal/4577/457755452012/movil en http://www.redalyc.org/revista.oa?id=4577 Revista Médica del Instituto Mexicano del Seguro Social application/pdf Instituto Mexicano del Seguro Social Revista Médica del Instituto Mexicano del Seguro Social (México) Num.4 Vol.55
title Clinical evaluation of diabetic neuropathy in adult patients with type 1 diabetes and its possible association with insulin resistance
topic Medicina
Type 1
Diabetes Mellitus
Metabolic Syndrome
Diabetic Neuropathies
url https://www.redalyc.org/articulo.oa?id=457755452012
https://www.redalyc.org/journal/4577/457755452012/
https://www.redalyc.org/journal/4577/457755452012/html/
https://www.redalyc.org/journal/4577/457755452012/457755452012.epub
https://www.redalyc.org/journal/4577/457755452012/movil